Table 1. Characteristics of Patients during Admission.
| Total |
Visit in outpatient within 6 months after onset of stroke |
ESUS | CE | LAA | SVD | |||
|---|---|---|---|---|---|---|---|---|
| Yes | No | P | ||||||
| Number | 511 | 391 | 120 | 209 | 136 | 84 | 82 | |
| Age (years)Median | 74 | 72 | 80 | ＜0.01 | 72 | 79 | 73 | 70 |
| IQR | 65-81 | 63-79 | 70-85 | 61-79 | 69-83 | 67-81 | 60-77 | |
| Men, % | 60.5 | 62.7 | 53.0 | 0.06 | 61.7 | 55.2 | 71.4 | 54.9 |
| Body-mass index | 23.2 | 23.7 | 22.0 | ＜0.01 | 23.6 | 22.0 | 24.3 | 24.3 |
| IQR | 21-26 | 21-26 | 20-24 | 21-26 | 21-26 | 21-26 | 21-27 | |
| NIHSS at admission | 2 | 2 | 5 | ＜0.01 | 2 | 3 | 3 | 2 |
| IQR | 1-5 | 1-4 | 2-11 | 1-4 | 1-9 | 1-5 | 1-3 | |
| mRS at discharge | 1 | 1 | 3 | ＜0.01 | 1 | 2 | 1 | 1 |
| IQR | 0-3 | 0-2 | 1-4 | 0-1 | 1-3 | 0-3 | 0-1 | |
| Admission period, days | 18 | 16 | 29 | ＜0.01 | 17 | 22 | 20 | 13 |
| IQR | 13-28 | 12-22 | 18-44 | 13-24 | 14-36 | 14-29 | 11-19 | |
| All death (%) | 3 (0.6) | 1 (0.5) | 2 (1.5) | 0 | 0 | |||
| Discharge to home, % | 79.1 | 89.0 | 34.2 | ＜0.01 | 83.9 | 71.6 | 69.0 | 86.7 |
| History of hypertension, % | 77.5 | 76.3 | 81.2 | 0.27 | 76.6 | 72.8 | 79.5 | 85.4 |
| Diabetes mellitus, % | 40.1 | 40.3 | 39.3 | 0.85 | 43.5 | 31.1 | 45.8 | 54.9 |
| Dyslipidemia, % | 50.3 | 53.1 | 41.0 | 0.02 | 51.7 | 39.7 | 59.8 | 54.9 |
| CHF, % | 10.6 | 8.9 | 16.2 | 0.02 | 5.3 | 25.0 | 8.3 | 2.4 |
| Ischemic Heart Disease | 14.5 | 14.2 | 15.4 | 0.75 | 10.5 | 21.3 | 20.2 | 7.3 |
| Chronic kidney disease, % | 28.2 | 27.7 | 29.9 | 0.65 | 18.7 | 41.2 | 31.3 | 28.1 |
| Atrial fibrillation | 22.8 | 17.6 | 40.2 | ＜0.01 | 0.0 | 82.4 | 3.6 | 0.0 |
| Current Smoking, % | 16.1 | 18.2 | 9.0 | 0.02 | 23.0 | 4.0 | 15.7 | 18.4 |
| eGFR | 61.1 | 61.1 | 59.8 | 0.44 | 64.3 | 46.6 | 60.6 | 64.9 |
| IQR | 41-75 | 42-74 | 34-77 | 48-79 | 32-70 | 38-70 | 47-77 | |
| LDL cholesterol mg/dl | 113 | 113 | 111 | 0.43 | 112 | 106 | 122 | 122 |
| IQR | 89-140 | 89-142 | 85-138 | 90-138 | 83-130 | 88-156 | 99-147 | |
| HDL cholesterol mg/dl | 53 | 53 | 54 | 0.70 | 52 | 56 | 49 | 54 |
| IQR | 41-66 | 41-67 | 41-65 | 41-68 | 46-68 | 39-59 | 40-69 | |
| Triglycerides mg/dl | 109 | 114 | 97 | 0.01 | 113 | 92 | 128 | 128 |
| IQR | 77-156 | 80-167 | 71-139 | 81-156 | 66-138 | 82-188 | 77-193 | |
| HbA1c (%) | 6.1 | 6.1 | 6.0 | 0.59 | 6.0 | 6.0 | 6.4 | 6.1 |
| IQR | 5.7-7.1 | 5.7-7.2 | 5.6-7.0 | 5.7-7.2 | 5.6-6.7 | 5.8-7.2 | 5.7-7.3 | |
| Brain Natriuretic Protein, mg/dl | 62.6 | 52.9 | 166.3 | ＜0.01 | 46.1 | 233.1 | 44.2 | 41.6 |
| IQR | 27-177 | 25-126 | 47-366 | 20-89 | 102-447 | 24-150 | 22-83 | |
| Treatment with alteplase, % | 6.3 | 5.1 | 10.5 | 0.04 | 4.8 | 11.2 | 8.6 | 0.0 |
| Endovascular treatment, % | 6.8 | 1.8 | 6.2 | 0.01 | 1.5 | 6.9 | 2.5 | 0.0 |
| Anti-platelet drug at discharge, % | 71.3 | 75.8 | 56.4 | ＜0.01 | 83.2 | 22.2 | 96.4 | 96.3 |
| Anti-coagulant at discharge, % | 34.2 | 29.6 | 49.6 | ＜0.01 | 16.4 | 94.0 | 13.3 | 2.5 |
| Statin at discharge, % | 66.0 | 70.2 | 52.1 | ＜0.01 | 66.5 | 45.2 | 90.5 | 74.1 |
Data are median and interquartile range (IQR) or number (%). ESUS; embolic stroke of undetermined source, CE; cardioembolism, LAA: large artery atherosclerosis, SVD, small vessel disease, AF; atrial fibrillation. TIA; transient ischemic attack. CHF; congestive heart failure, mRS; modified Rankin scale, NIHSS; national institute of health stroke scale.
# Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m 2 of body-surface area.